婴儿期皮肤润肤剂与早期辅食添加预防特应性皮炎(PreventADALL):析因多中心整群随机试验
本研究为基于人群的2×2析因整群随机试验,纳入2397名新生儿,评估从2周龄起规律使用皮肤润肤剂或12-16周龄早期添加辅食能否降低12月龄特应性皮炎发生率。
要点
- 早期规律使用润肤剂未降低12月龄特应性皮炎风险。
- 12-16周龄早期添加花生、牛奶、小麦、鸡蛋未降低特应性皮炎风险。
- 干预未发现安全性问题,皮肤症状频率未增加。
核心结论
- 早期皮肤润肤剂或早期辅食添加均不能降低12月龄婴儿特应性皮炎的发生风险。
研究设计与样本
- 研究为基于人群的2×2析因、整群随机临床试验,在挪威和瑞典的三家医院进行。
- 2015至2017年间纳入2397名新生儿,按92个地理居住区组和8个3个月时间组进行整群随机分组。
- 干预包括从2周龄起使用润肤剂(洗浴添加剂和面霜)和12-16周龄早期添加花生、牛奶、小麦、鸡蛋,要求每周至少4天应用。
- 主要结局为12月龄时经盲法临床评估诊断的特应性皮炎,采用UK工作组和Hanifin-Rajka标准。
- 主要疗效分析为意向性治疗分析。
主要发现
- 无干预组特应性皮炎发生率为8%(48/596),皮肤干预组为11%(64/575),食物干预组为9%(58/642),联合干预组为5%(31/583)。
- 干预未发现安全性问题,皮肤干预组、食物干预组和联合干预组报告的皮肤症状和体征(包括瘙痒、水肿、皮疹、皮肤干燥和荨麻疹)频率不高于无干预组。
临床怎么用
- 本研究结果不支持使用早期皮肤润肤剂或早期辅食添加来预防12月龄婴儿特应性皮炎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Skin emollients applied during early infancy could prevent atopic dermatitis, and early complementary food introduction might reduce food allergy in high-risk infants. The study aimed to determine if either regular skin emollients applied from 2 weeks of age, or early complementary feeding introduced between 12 and 16 weeks of age, reduced development of atopic dermatitis by age 12 months in the general infant population. METHODS: This population-based 2×2 factorial, randomised clinical trial was done at Oslo University Hospital and Østfold Hospital Trust, Oslo, Norway; and Karolinska University Hospital, Stockholm, Sweden. Infants of women recruited antenatally at the routine ultrasound pregnancy screening at 18 weeks were cluster-randomised at birth from 2015 to 2017 to the following groups: (1) controls with no specific advice on skin care while advised to follow national guidelines on infant nutrition (no intervention group); (2) skin emollients (bath additives and facial cream; skin intervention group); (3) early complementary feeding of peanut, cow's milk, wheat, and egg (food intervention group); or (4) combined skin and food interventions (combined intervention group). Participants were randomly assigned (1:1:1:1) using computer- generated cluster randomisation based on 92 geographical living area blocks as well as eight 3-month time blocks. Carers were instructed to apply the interventions on at least 4 days per week. Atopic dermatitis by age 12 months was the primary outcome, based on clinical investigations at 3, 6 and 12 months by investigators masked to group allocation. Atopic dermatitis was assessed after completing the 12-month investigations and diagnosed if either of the UK Working Party and Hanifin and Rajka (12 months only) diagnostic criteria were fulfilled. The primary efficacy analyses was done by intention-to-treat analysis on all randomly assigned participants. Food allergy results will be reported once all investigations at age 3 years are completed in 2020. This was a study performed within ORAACLE (the Oslo Research Group of Asthma and Allergy in Childhood; the Lung and Environment). The study is registered at clinicaltrials.gov, NCT02449850. FINDINGS: 2697 women were recruited between Dec 9, 2014, and Oct 31, 2016, from whom 2397 newborn infants were enrolled from April 14, 2015, to April 11, 2017. Atopic dermatitis was observed in 48 (8%) of 596 infants in the no intervention group, 64 (11%) of 575 in the skin intervention group, 58 (9%) of 642 in the food intervention group, and 31 (5%) of 583 in the combined intervention group. Neither skin emollients nor early complementary feeding reduced development of atopic dermatitis, with a risk difference of 3·1% (95% CI -0·3 to 6·5) for skin intervention and 1·0% (-2·1 to 4·1) for food intervention, in favour of control. No safety concerns with the interventions were identified. Reported skin symptoms and signs (including itching, oedema, exanthema, dry skin, and urticaria) were no more frequent in the skin, food, and combined intervention groups than in the no intervention group. INTERPRETATION: Neither early skin emollients nor early complementary feeding reduced development of atopic dermatitis by age 12 months. Our study does not support the use of these interventions to prevent atopic dermatitis by 12 months of age in infants. FUNDING: The study was funded by several public and private funding bodies: The Regional Health Board South East, The Norwegian Research Council, Health and Rehabilitation Norway, The Foundation for Healthcare and Allergy Research in Sweden-Vårdalstiftelsen, Swedish Asthma and Allergy Association's Research Foundation, Swedish Research Council-the Initiative for Clinical Therapy Research, The Swedish Heart-Lung Foundation, SFO-V at the Karolinska Institute, Freemason Child House Foundation in Stockholm, Swedish Research Council for Health, Working Life and Welfare-FORTE, Oslo University Hospital, the University of Oslo, and Østfold Hospital Trust.
引用
- Skjerven HO, Rehbinder EM, Vettukattil R, et al. Skin emollient and early complementary feeding to prevent infant atopic dermatitis (PreventADALL): a factorial, multicentre, cluster-randomised trial. Lancet. 2020. PMID: 32087121. doi:10.1016/S0140-6736(19)32983-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。